| Walter D Bramson Md A Professional Corporation | |
|
580 Forest Shade Rd Unit 1 Crestline CA 92325-3816 | |
| (909) 338-1851 | |
| (909) 338-6381 |
| Full Name | Walter D Bramson Md A Professional Corporation |
|---|---|
| Speciality | Clinic/Center |
| Location | 580 Forest Shade Rd Unit 1, Crestline, California |
| Authorized Official Name and Position | Walter David Bramson (PRESIDENT) |
| Authorized Official Contact | 9093381851 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Walter D Bramson Md A Professional Corporation Po Box 3816 580 Forest Shade Rd Unit 1 Crestline CA 92325-3816 Ph: (909) 338-1851 | Walter D Bramson Md A Professional Corporation 580 Forest Shade Rd Unit 1 Crestline CA 92325-3816 Ph: (909) 338-1851 |
| NPI Number | 1700216488 |
|---|---|
| Provider Enumeration Date | 11/18/2013 |
| Last Update Date | 06/13/2014 |
| Medicare PECOS PAC ID | 4284858309 |
|---|---|
| Medicare Enrollment ID | O20140611001864 |
News Archive
In a new, first-of-its-kind study, researchers from Case Western Reserve University School of Medicine have found a 700-percent surge in infections caused by bacteria from the Enterobacteriaceae family resistant to multiple kinds of antibiotics among children in the US. These antibiotic resistant infections are in turn linked to longer hospital stays and potentially greater risk of death.
Tecomet Inc., a Genstar Capital portfolio company and precision contract manufacturer supporting the medical device and aerospace industries, announced today that it has completed the previously announced acquisition of Symmetry Medical's OEM Solutions business. This acquisition creates the largest orthopedic contract manufacturer in the world with 18 facilities located in five countries on three continents.
Targacept, Inc. announced today that it is offering to sell $75 million in shares of its common stock in an underwritten public offering. Targacept expects to grant the underwriters for the offering an option to purchase additional shares of common stock to cover over-allotments, if any.
Even as California prepares to expand vaccine eligibility on April 15 to all residents age 16 and up, the state has managed to inoculate only about half its senior population — the 65-and-older target group deemed most vulnerable to death and serious illness in the pandemic.
› Verified 5 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1700216488 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261Q00000X | Clinic/center | G40647 (California) | Primary |
| Provider Name | Walter D Bramson |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1033167119 PECOS PAC ID: 2860681491 Enrollment ID: I20110112000524 |
News Archive
In a new, first-of-its-kind study, researchers from Case Western Reserve University School of Medicine have found a 700-percent surge in infections caused by bacteria from the Enterobacteriaceae family resistant to multiple kinds of antibiotics among children in the US. These antibiotic resistant infections are in turn linked to longer hospital stays and potentially greater risk of death.
Tecomet Inc., a Genstar Capital portfolio company and precision contract manufacturer supporting the medical device and aerospace industries, announced today that it has completed the previously announced acquisition of Symmetry Medical's OEM Solutions business. This acquisition creates the largest orthopedic contract manufacturer in the world with 18 facilities located in five countries on three continents.
Targacept, Inc. announced today that it is offering to sell $75 million in shares of its common stock in an underwritten public offering. Targacept expects to grant the underwriters for the offering an option to purchase additional shares of common stock to cover over-allotments, if any.
Even as California prepares to expand vaccine eligibility on April 15 to all residents age 16 and up, the state has managed to inoculate only about half its senior population — the 65-and-older target group deemed most vulnerable to death and serious illness in the pandemic.
› Verified 5 days ago
News Archive
In a new, first-of-its-kind study, researchers from Case Western Reserve University School of Medicine have found a 700-percent surge in infections caused by bacteria from the Enterobacteriaceae family resistant to multiple kinds of antibiotics among children in the US. These antibiotic resistant infections are in turn linked to longer hospital stays and potentially greater risk of death.
Tecomet Inc., a Genstar Capital portfolio company and precision contract manufacturer supporting the medical device and aerospace industries, announced today that it has completed the previously announced acquisition of Symmetry Medical's OEM Solutions business. This acquisition creates the largest orthopedic contract manufacturer in the world with 18 facilities located in five countries on three continents.
Targacept, Inc. announced today that it is offering to sell $75 million in shares of its common stock in an underwritten public offering. Targacept expects to grant the underwriters for the offering an option to purchase additional shares of common stock to cover over-allotments, if any.
Even as California prepares to expand vaccine eligibility on April 15 to all residents age 16 and up, the state has managed to inoculate only about half its senior population — the 65-and-older target group deemed most vulnerable to death and serious illness in the pandemic.
› Verified 5 days ago